Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II)
Citations Over TimeTop 10% of 1993 papers
Abstract
The mutagenicity and genotoxicity of cis-[Pt(NH3)2[d(GpG)-N7(1),-N7(2)]] (G*G*), the major DNA adduct of the antitumor drug cisplatin, has been investigated in Escherichia coli. A duplex bacteriophage M13 genome was constructed to contain the G*G* adduct at a specific site in the (-) strand. The singly platinated duplex genome exhibited a survival of 22% relative to that of the unplatinated control genomes, and this value rose to 38% in cells treated with ultraviolet light to induce the SOS response. Singly platinated single-stranded genomes were also produced. Replication of the single- and double-stranded genomes in vivo yielded SOS-dependent, targeted mutations at frequencies of 1.3% and 0.16%, respectively. The mutagenic specificity of G*G* in both single- and double-stranded DNA was striking in that 80-90% of the mutations occurred at the 5'-platinated G. Approximately 80% of the mutations were G-->T transversions at that site. A model of mutagenesis is presented to explain this mutational specificity with respect to current understanding of platinum-DNA adduct structure.
Related Papers
- → Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations(2008)87 cited
- → Effect of conformation of the arylamine-DNA adduct on the sensitivity of [Ru(phen)2(dppz)]2+ complex(2016)6 cited
- → Aromatic DNA adducts in lymphocytes of humans working at high and low traffic density areas(1996)34 cited
- → 32P-postlabelling analysis of DNA adducts from Fischer-344 rats administered 2,4-diaminotoluene(1992)15 cited
- → Analysis of an RNA adduct formed from aminophenylnorharman(2009)2 cited